Alnylam Pharmaceuticals, Inc. (0HD2.L)

USD 243.84

(-0.72%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.82 Billion 3.54 Billion 3.64 Billion 3.4 Billion 2.39 Billion 1.57 Billion
Total Current Assets 2.98 Billion 2.69 Billion 2.8 Billion 2.61 Billion 1.71 Billion 1.2 Billion
Cash And Short Term Investments 2.43 Billion 2.19 Billion 2.43 Billion 1.87 Billion 1.53 Billion 1.08 Billion
Cash and Cash Equivalents 812.68 Million 866.39 Million 822.15 Million 499.04 Million 547.18 Million 420.37 Million
Short Term Investments 1.62 Billion 1.32 Billion 1.61 Billion 1.37 Billion 988.98 Million 664 Million
Net Receivables 327.78 Million 237.96 Million 198.57 Million 602.41 Million 43.01 Million 18.76 Million
Inventory 89.14 Million 128.96 Million 86.36 Million 75.2 Million 56.34 Million 24.06 Million
Other Current Assets 126.38 Million 132.91 Million 85.9 Million 60.3 Million 80.33 Million 73.48 Million
Total Non-Current Assets 847.18 Million 854.11 Million 834.72 Million 792.28 Million 679.27 Million 374.1 Million
Net PPE 725.78 Million 738.63 Million 733.63 Million 706.51 Million 646.37 Million 320.65 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 51.58 Million 51.55 Million 40.89 Million 40.72 Million 17.27 Million 47.08 Million
Tax Assets - - - - - -
Other Non Current Assets 69.8 Million 63.93 Million 60.2 Million 45.04 Million 15.62 Million 6.36 Million
Other Assets - - - - - -
Total Liabilities 4.05 Billion 3.7 Billion 3.05 Billion 2.39 Billion 956.44 Million 272.83 Million
Total Current Liabilities 967.78 Million 767.91 Million 695.71 Million 585.27 Million 352.59 Million 179.49 Million
Account Payables 55.51 Million 98.09 Million 73.42 Million 51.96 Million 49.88 Million 59.7 Million
Tax Payables - - - - - -
Short Term Debt 54.99 Million 82.25 Million 77.62 Million 50.18 Million 27.68 Million -
Deferred Revenue 102.75 Million 42.1 Million 149.48 Million 127.2 Million 77.82 Million 3.49 Million
Other Current Liabilities 754.52 Million 545.46 Million 395.17 Million 355.9 Million 197.2 Million 116.29 Million
Total Non Current Liabilities 3.08 Billion 2.93 Billion 2.35 Billion 1.8 Billion 603.84 Million 93.34 Million
Long-Term Debt 2.34 Billion 2.26 Billion 1.82 Billion 1.24 Billion 276.13 Million 30 Million
Deferred Revenue Non Current 188.17 Million 193.79 Million 152.36 Million 225.09 Million 318.38 Million 458 Thousand
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 308.43 Million 212.58 Million 98.96 Million 37.9 Million 9.33 Million 62.88 Million
Other Liabilities - - - 1.00 - 1.00
Total Equity -220.64 Million -158.22 Million 588.2 Million 1.01 Billion 1.43 Billion 1.3 Billion
Stock Holders Equity -220.64 Million -158.22 Million 588.2 Million 1.01 Billion 1.43 Billion 1.3 Billion
Common Stock 1.25 Million 1.24 Million 1.2 Million 1.16 Million 1.12 Million 1.01 Million
Retained Earnings -7 Billion -6.56 Billion -5.43 Billion -4.58 Billion -3.72 Billion -2.84 Billion
Accumulated other comprehensive income -23.37 Million -44.65 Million -33.25 Million -43.62 Million -36.51 Million -33.21 Million
Common Stock Equity -220.64 Million -158.22 Million 588.2 Million 1.01 Billion 1.43 Billion 1.3 Billion
Capital Lease Obligation 284.61 Million 261.33 Million 281.34 Million 293.03 Million 276.13 Million -
Total Investments 1.62 Billion 1.37 Billion 1.65 Billion 1.41 Billion 1 Billion 711.09 Million
Total Debt 2.39 Billion 2.61 Billion 2.18 Billion 1.59 Billion 303.82 Million 30 Million
Net Debt 1.58 Billion 1.74 Billion 1.36 Billion 1.09 Billion -243.35 Million -390.37 Million

Balance Sheet Charts